Location History:
- Scotland, GB (2020)
- Glasgow, GB (2022)
Company Filing History:
3 out of 280 
2 out of 5,089 
1 out of 1 
Years Active: 2020-2022
Title: Alan Crozier: Innovator in Diabetes Research
Introduction
Alan Crozier is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of diabetes research, particularly through his innovative patents. With a total of two patents to his name, Crozier's work focuses on the stimulation of insulin secretion and the prevention of diabetes mellitus.
Latest Patents
Crozier's latest patents include compositions comprising urolithins and their uses for stimulating insulin secretion. The first patent details a composition that includes urolithin A, B, C, D, or a combination thereof, aimed at enhancing insulin secretion. Additionally, it addresses the treatment and prevention of diabetes mellitus, specifically type 2 diabetes, using effective amounts of urolithin B, C, D, or their combinations. This innovative approach highlights the potential of urolithins in managing diabetes.
Career Highlights
Throughout his career, Alan Crozier has worked with esteemed institutions such as Université de Montpellier and the Centre National de la Recherche Scientifique. His research has contributed to a deeper understanding of diabetes and potential therapeutic solutions.
Collaborations
Some of Crozier's notable coworkers include Gerard Cros and Margherita Dall'asta. Their collaborative efforts have further advanced research in the field of diabetes.
Conclusion
Alan Crozier's innovative work in diabetes research, particularly through his patents on urolithins, showcases his commitment to improving health outcomes. His contributions are significant in the ongoing fight against diabetes.